Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0003 Transporter Info | ||||
Gene Name | ABCB1 | ||||
Transporter Name | P-glycoprotein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | p,p'-dichlorodiphenyldichloroethane (DDE) | ||||
Xenobiotic Type | Environmental toxicant | ||||
MOA | Inhibition | ||||
PubChem CID | 6294 | ||||
Docking Score | -8.03 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C14H10Cl4 | ||||
Molecular Weight | 320 | ||||
Canonical SMILES |
C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
|
||||
InChI |
InChI=1S/C14H10Cl4/c15-11-5-1-9(2-6-11)13(14(17)18)10-3-7-12(16)8-4-10/h1-8,13-14H
|
||||
InChIKey | AHJKRLASYNVKDZ-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 6.2 | Rotatable Bond Count | 3 | |
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 0 | ||
Xenobiotic Name | Miltirone Drug Info | ||||
Xenobiotic Type | Discontinued Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 160142 | ||||
Docking Score | -7.988 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C19H22O2 | ||||
Molecular Weight | 282.4 | ||||
Canonical SMILES |
CC(C)C1=CC2=C(C3=C(C=C2)C(CCC3)(C)C)C(=O)C1=O
|
||||
InChI |
InChI=1S/C19H22O2/c1-11(2)14-10-12-7-8-15-13(6-5-9-19(15,3)4)16(12)18(21)17(14)20/h7-8,10-11H,5-6,9H2,1-4H3
|
||||
InChIKey | FEFAIBOZOKSLJR-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 4.9 | Rotatable Bond Count | 1 | |
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | ||
Xenobiotic Name | Epothilone D Drug Info | ||||
Xenobiotic Type | Discontinued Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 447865 | ||||
Docking Score | -7.939 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C27H41NO5S | ||||
Molecular Weight | 491.7 | ||||
Canonical SMILES |
C[C@H]1CCC/C(=C\\C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C2=CSC(=N2)C)/C)/C
|
||||
InChI |
InChI=1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1
|
||||
InChIKey | XOZIUKBZLSUILX-GIQCAXHBSA-N | ||||
Pharmaceutical Properties | Xlogp | 5 | Rotatable Bond Count | 2 | |
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
Pagination
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.